Previous Recipient List

  • Professor Chris Cunningham
    Massey University, Wellington
    Best Health for Māori: Te Hoe Nuku Roa - Housing, Hazards and Health
    $786,852
    36 months
  • Professor Gregory Cook
    University of Otago, Dunedin
    Repurposing amiloride derivatives as new agents for drug-resistant tuberculosis
    $1,186,404
    36 months
  • Dr Haxby Abbott
    University of Otago
    Decreasing pain, disability, waiting lists and costs of osteoarthritis
    $646,762
    36 months
  • Associate Professor Haxby Abbott
    University of Otago, Dunedin
    The impact and management of rising osteoarthritis burden
    $1,197,719
    36 months
  • Professor Haxby Abbott
    University of Otago, Dunedin
    The primary care management and impact of osteoarthritis: learning from big data
    $1,199,993
    36 months
  • Dr Istvan Abraham
    University of Otago, Dunedin
    ANGELS as a Potential Treatment for Alzheimer's Disease
    $782,886
    36 months
  • Associate Professor Wickliffe Abraham
    University of Otago
    Mechanisms of secreted amyloid precursor protein regulation of synaptic plasticity
    $1,024,344
    36 months
  • Professor Wickliffe Abraham
    University of Otago, Dunedin
    Astrocyte-neuron communication in a novel homeostatic form of metaplasticity
    $569,000
    36 months
  • Professor Wickliffe Abraham
    University of Otago, Dunedin
    Mechanisms of neural network metaplasticity via astrocytes
    $1,175,591
    36 months
  • Dr David Ackerley
    Victoria University of Wellington
    Biodiscovery and biosynthesis of new drug candidates
    $1,195,266
    36 months
  • Professor David Ackerley
    Victoria University of Wellington
    Repurposing the anthelmentic niclosamide to combat Gram negative superbugs
    $1,189,475
    36 months
  • Dr Philip Adamson
    University of Otago
    Duration of dual antiplatelet therapy in acute coronary syndrome (DUAL-ACS)
    $1,549,999
    48 months
  • Ms Annabel Ahuriri-Driscoll
    Institute of Environmental Science & Research Ltd
    Te Tomokanga: a model for facilitating bicultural health policy and programme development
    $350,000
    18 months
  • Dr Siautu Alefaio-Tugia
    Massey University, Auckland
    Caring for our Wisdom Bearers: Pacific Matua (Elder) care
    $599,713
    36 months
  • Professor Shanthi Ameratunga
    The University of Auckland
    M-health Delivery for Reducing Alcohol in the Trauma Environment (MoDeRATE) Trial
    $1,185,265
    36 months
  • Professor Shanthi Ameratunga
    The University of Auckland
    Determinants of life-threatening injuries among young and middle-aged adults
    $789,352
    36 months
  • Professor Shanthi Ameratunga
    University of Auckland
    Towards streetscapes promoting inclusive mobility, health and wellbeing for all
    $1,188,467
    36 months
  • Associate Professor Robert Anderson
    The University of Auckland
    Potent Reactive Radicals as Hypoxia-Selective Cytotoxins for Cancer Treatment
    $1,194,225
    36 months
  • Associate Professor Robert Anderson
    The University of Auckland
    Prodrug release of kinase inhibitors in cancer therapy
    $719,625
    36 months
  • Associate Professor Robert Anderson
    The University of Auckland
    Free radical studies and disease
    $1,405,446
    36 months
  • Professor Tim Anderson
    University of Otago, Dunedin
    Genetics, brain imaging, and cognitive decline in Parkinson's disease
    $1,178,804
    36 months
  • Associate Professor Greg Anderson
    University of Otago, Dunedin
    Targeting the RFRP neuronal system to control stress and anxiety
    $1,189,211
    36 months
  • Associate Professor Vickery Arcus
    University of Waikato
    The role of the toxin-antitoxin repertoire in pathogen survival and persistence
    $843,987
    36 months
  • Professor Bruce Arroll
    The University of Auckland
    Trial of a NZ developed screening questionnaire compared with a standard screen
    $581,755
    19 months
  • Dr Thomas Backstrom
    Malaghan Institute of Medical Research
    Inhibition of autoimmune diseases by superantigen-peptide conjugates
    $923,425
    36 months
  • Professor Edward Baker
    The University of Auckland
    Structural and molecular basis of host-pathogen interactions
    $1,496,780
    36 months
  • Professor Edward Baker
    The University of Auckland
    A targeted application of structural genomics to TB biology and drug development
    $1,375,181
    36 months
  • Professor Michael Baker
    University of Otago, Wellington
    Understanding GAS pharyngitis and skin infections as causes of rheumatic fever
    $1,197,693
    36 months
  • Professor Michael Baker
    University of Otago, Wellington
    Developing an optimal strategy for the rheumatic fever endgame
    $1,196,974
    36 months
  • Ms Mere Balzer
    Te Runanga o Kirikiriroa Charitable Trust
    Whanau Māori & mental health: Snapshots of strengths, resilience & recovery
    $132,483
    18 months
  • Dr Suzanne Barker-Collo
    Auckland UniServices Ltd
    Reducing post-stroke attention deficits: Extending a randomised controlled trial
    $60,000
    36 months
  • Dr Suzanne Barker-Collo
    Auckland UniServices Ltd
    Reducing post-stroke attention deficits: a randomised controlled trial
    $479,032
    36 months
  • Professor Richard Beasley
    Medical Research Institute of New Zealand, Wellington
    Randomised Placebo-controlled Trial of Paracetamol in Febrile Septic Patients
    $1,197,966
    36 months
  • Professor Richard Beasley
    Medical Research Institute of New Zealand
    A randomised placebo-controlled trial of paracetamol use in influenza
    $747,053
    18 months
  • Professor Richard Beasley
    Medical Research Institute of New Zealand
    RCT of regular paracetamol in mild to moderate asthma
    $342,220
    24 months
  • Professor Richard Beasley
    Medical Research Institute of New Zealand
    Pharmacotherapy for the different phenotypes of airways disease
    $1,200,000
    36 months
  • Professor Richard Beasley
    Medical Research Institute of New Zealand
    The Real Life Use of Symbicort "Smart" Regime in Adult Asthma
    $1,302,654
    36 months
  • Professor Richard Beasley
    Medical Research Institute of New Zealand
    Bronchodilator efficacy of inhaled magnesium in acute severe asthma and COPD
    $1,120,318
    24 months
  • Professor Richard Beasley
    Medical Research Institute of New Zealand
    Two RCTs of salbutamol therapy in exacerbations of asthma in adults
    $578,713
    36 months
  • Professor Evan Begg
    University of Otago, Christchurch
    Free drug metabolic clearance in older adults
    $326,366
    24 months
  • Professor Laura Bennet
    The University of Auckland
    Can Pluripotent Amnion Epithelial Cells help the Injured Preterm Brain?
    $1,154,402
    36 months
  • Dr Jackie Benschop
    Massey University, Palmerston North
    Emerging sources and pathways for Leptospirosis - a paradigm shift
    $1,199,841
    36 months
  • Dr Peter Bergin
    Auckland District Health Board
    Incidence study of Status Epilepticus in the greater Auckland region
    $671,783
    60 months
  • Dr Peter Bergin
    Auckland District Health Board
    International case-control study of sudden unexpected death in epilepsy
    $1,190,647
    48 months
  • Professor Michael Berridge
    Malaghan Institute of Medical Research
    Intercellular mitochondrial transfer in glioblastoma
    $1,095,885
    36 months
  • Associate Professor David Bilkey
    University of Otago, Dunedin
    Hippocampal processing of context in schizophrenia
    $796,117
    36 months
  • Dr David Bilkey
    University of Otago
    Hippocampal processing of context in schizophrenia
    $415,008
    24 months
  • Professor David Bilkey
    University of Otago
    A novel biomarker for preclinical drug development in schizophrenia
    $489,282
    24 months
  • Associate Professor Peter Black
    The University of Auckland
    The effect of an inhaler with ringtones on asthma control and school attendance
    $428,355
    24 months
  • Associate Professor Tony Blakely
    University of Otago
    Cancer trends: Ethnic and socio-economic trends in cancer incidence and survival
    $924,356
    36 months
  • Dr Francis Bloomfield
    The University of Auckland
    Periconceptional regulation of fetal growth and adult physiology: studies in twins
    $682,734
    24 months
  • Professor Frank Bloomfield
    The University of Auckland
    ProViDe RCT: Does better early nutrition in preterm babies improve development?
    $1,194,159
    60 months
  • Professor Frank Bloomfield
    University of Auckland
    Reducing inequity through timely detection of critical congenital heart disease
    $1,184,577
    36 months
  • Dr Mark Bolland
    The University of Auckland
    Zoledronic Acid and Fracture Prevention in Early Postmenopausal Women
    $1,159,604
    60 months
  • Associate Professor Mark Bolland
    University of Auckland
    Zoledronic acid and fracture prevention in early postmenopausal women
    $962,994
    48 months
  • Ms Belinda Borell
    Massey University
    Conferred privilege and structural advantage - the health implications
    $852,482
    36 months
  • Dr Amohia Boulton
    Te Maruo Ruahine Trust/Whakauae Research for Maori Health & Development
    Supporting Traditional Rongoa Practice in Contemporary Health Care Settings
    $1,023,301
    36 months
  • Dr Amohia Boulton
    Whakauae Research Services Limited
    D3: Data, decision-making and development: Using data to improve health outcomes
    $1,199,996
    36 months
  • Professor Antony Braithwaite
    University of Otago
    Can isoforms of the p53 tumour suppressor cause cancer?
    $1,158,492
    36 months
  • Professor Antony Braithwaite
    University of Otago, Dunedin
    Does the D133p53 isoform promote cancer invasion and metastasis?
    $1,185,648
    36 months
  • Professor Anthony Braithwaite
    University of Otago, Dunedin
    A role for p53 isoforms in inflammatory disease
    $1,176,905
    36 months
  • Professor Bernhard Breier
    Massey University, Auckland
    The gut microbiome: a new pathway to obesity prevention and metabolic health
    $1,199,468
    36 months
  • Professor Margaret Brimble
    University of Auckland
    New generation lipopeptide antimicrobial agents using patented CLipPA technology
    $1,199,021
    36 months
  • Professor Margaret Brimble
    The University of Auckland
    Naturally occurring peptaibols: “Magic bullets” for targeting breast cancer
    $1,195,373
    36 months
  • Dr Jonathan Broadbent
    University of Otago, Dunedin
    Oral health from childhood to mid-life
    $1,193,937
    60 months
  • Dr Rebecca Brookland
    University of Otago, Dunedin
    Older drivers, families and GPs: Navigating the path between mobility and safety
    $1,193,921
    36 months
  • Dr Rebecca Brookland
    University of Otago, Dunedin
    Predictors and impact of driving cessation on older adults and whanau/families
    $1,199,989
    48 months
  • Dr Colin Brown
    University of Otago
    Kisspeptin-oxytocin regulation of pregnancy: implications for preterm delivery
    $709,665
    36 months
  • Dr Colin Brown
    University of Otago, Dunedin
    Central regulation of natural birth processes
    $1,003,783
    36 months
  • Dr Christopher Bullen
    The University of Auckland
    Electronic cigarettes for smoking cessation: a randomised controlled trial
    $1,199,155
    36 months
  • Professor Christopher Bullen
    University of Auckland
    No smokers left behind: A trial of adaptive smoking cessation treatment
    $1,197,725
    36 months
  • Associate Professor Winston Byblow
    The University of Auckland
    Priming to enhance rehabilitation after stroke
    $812,955
    36 months
  • Professor Winston Byblow
    The University of Auckland
    Individualised neuromodulation for motor recovery after stroke
    $1,179,896
    36 months
  • Dr Catherine Byrnes
    The University of Auckland
    Interventional study on bronchiectasis in indigenous children
    $555,895
    30 months
  • Dr Rebecca Campbell
    University of Otago, Dunedin
    Understanding the Neuroendocrine Abnormalities of Polycystic Ovarian Syndrome
    $650,735
    36 months
  • Dr Rebecca Campbell
    University of Otago, Dunedin
    Probing novel pathways mediating polycystic ovarian syndrome
    $910,114
    36 months
  • Dr Philip Carter
    Institute of Environmental Science & Research
    Evolution of an epidemic: emergence and adaptation of group B meningococci in New Zealand
    $1,188,701
    36 months
  • Professor Sally Casswell
    Massey University
    The range and magnitude of alcohol's harm to others
    $853,355
    24 months
  • Professor Sally Casswell
    Massey University
    Measuring impacts of alcohol marketing on young New Zealanders
    $1,016,111
    36 months
  • Professor Sally Casswell
    Massey University, Auckland
    Alcohol Policy Interventions in New Zealand (APINZ)
    $1,197,020
    36 months
  • Professor Sally Casswell
    Massey University, Auckland
    Alcohol Policy Interventions in New Zealand (APINew Zealand) - effects of change in sale and supply
    $1,191,469
    36 months
  • Professor Sally Casswell
    Massey University, Auckland
    Assessing and comparing national policy to reduce harmful use of alcohol
    $869,563
    36 months
  • Professor Sally Casswell
    Massey University, Auckland
    Quantifying the disease burden of alcohol's harm to others
    $997,774
    36 months
  • Professor Kerry Chamberlain
    Massey University
    Medications in everyday life: Understandings and social practices
    $984,211
    36 months
  • Professor Stephen Chambers
    University of Otago
    Evaluation of a novel breath test for tuberculosis
    $593,993
    18 months
  • Professor Stephen Chambers
    University of Otago
    Breath test for aspergillus: role of 2-pentylfuran
    $645,850
    24 months
  • Professor Larry Chamley
    The University of Auckland
    A healthy life starts with a bio-energetically healthy placenta
    $1,193,142
    36 months
  • Professor Larry Chamley
    The University of Auckland
    Placental extracellular vesicles, controllers of the maternal vasculature
    $1,187,064
    36 months
  • Associate Professor Chris Charles
    University of Otago
    Sympathoinhibitory hormone Urocortin 2: Beneficial effects in cardiac injury?
    $1,057,693
    36 months
  • Professor James Chase
    The University of Canterbury
    PulMoDS: Pulmonary model-based decision support to optimise Acute Respiratory Distress Syndrome (ARDS)/ALI care
    $658,739
    36 months
  • Associate Professor Leo Cheng
    The University of Auckland
    Mechanisms of gastric dysmotility: Advances from cell to clinic
    $1,189,475
    36 months
  • Dr Melanie Cheung
    The University of Auckland
    Augmenting neuroplasticity in the Huntington's disease brain
    $1,189,942
    36 months
  • Dr Terryann Clark
    University of Auckland
    Harnessing the spark of life: Maximising whānau contributors to rangatahi wellbeing
    $1,198,178
    36 months
  • Dr Andrew Clarkson
    University of Otago, Dunedin
    Sonic Hedgehog Facilitates Post-Stroke Axonal Sprouting and Function Recovery
    $880,407
    36 months
  • Dr Linda Cobiac
    University of Otago, Wellington
    Choosing interventions to reduce alcohol-related harm
    $1,037,229
    36 months
  • Dr Sunny Collings
    University of Otago, Wellington
    The Nature and Extent of Informal Coercion in Community Mental Health in New Zealand
    $1,884,065
    36 months
  • Dr Adelaide Collins
    Māori Development Research Centre
    Māori with disabilities and their whanau navigating complex support systems
    $100,000
    36 months
  • Dr Michael Collins
    Auckland District Health Board
    The BEST-Fluids study: Better evidence for selecting transplant fluids
    $549,035
    48 months
  • Professor Martin Connolly
    The University of Auckland
    Aged Residential Care Healthcare Utilization Study
    $1,121,406
    36 months
  • Associate Professor Bronwen Connor
    The University of Auckland
    Cellular reprogramming: A unique approach to understanding Huntington's disease
    $1,190,497
    36 months
  • Professor Garth Cooper
    The University of Auckland
    Adiponectin: Molecular analysis to underpin therapeutic applications
    $1,658,677
    36 months
  • Dr Kirsten Coppell
    University of Otago, Dunedin
    What predicts regression from prediabetes to normal glucose regulation?
    $1,111,511
    36 months
  • Dr Donna Cormack
    University of Otago, Wellington
    Te whakahawea tangata: Decoding discrimination
    $334,994
    24 months
  • Dr Donna Cormack
    The University of Auckland
    Te whakahaumaru taiao: safe environments for Māori medical practitioners
    $994,669
    36 months
  • Associate Professor Brian Cox
    University of Otago, Dunedin
    Comparative Effectiveness Research: One-off Sigmoidoscopy or iFOBT Screening
    $666,038
    20 months
  • Associate Professor Brian Cox
    University of Otago, Dunedin
    The molecular pathological epidemiology of NHL
    $485,572
    18 months
  • Professor Julian Crane
    University of Otago, Wellington
    Nicotine inhaler plus patch in smoking cessation
    $1,353,242
    24 months
  • Professor Julian Crane
    University of Otago, Wellington
    Zonnic (oral nicotine) and nicotine patch in smoking cessation
    $1,116,305
    24 months
  • Professor Julian Crane
    University of Otago
    A pilot study for a national environmental intervention in childhood asthma
    $304,235
    12 months
  • Professor Julian Crane
    University of Otago, Wellington
    Carrageenan for the reduction of asthma exacerbations in adults
    $1,196,068
    36 months
  • Professor Julian Crane
    University of Otago, Wellington
    Preventing upper respiratory tract infections in infancy
    $1,198,436
    36 months
  • Professor Julian Crane
    University of Otago, Wellington
    Are toxic moulds a real health hazard in New Zealand?
    $1,193,603
    36 months
  • Professor Phillip Crosier
    The University of Auckland
    Uncovering mechanisms and inhibitors of tumour-induced lymphangiogenesis
    $1,199,342
    36 months
  • Dr David Crossman
    The University of Auckland
    Nanoscale fibrosis and loss of contractility in the failing human heart
    $1,182,220
    36 months
  • Dr Marie Crowe
    University of Otago, Christchurch
    A Randomised Clinical Effectiveness Trial of a Bipolar Disorder Clinic
    $1,189,961
    36 months
  • Professor Caroline Crowther
    The University of Auckland
    Optimal glycaemic targets for gestational diabetes: The randomised trial TARGET
    $1,198,858
    36 months
  • Professor Caroline Crowther
    The University of Auckland
    Gestational diabetes trial of detection thresholds: Impact on health and costs
    $1,199,330
    36 months
  • Professor Caroline Crowther
    The University of Auckland
    Antenatal magnesium sulphate: Mechanisms of fetal neuroprotection
    $1,199,011
    48 months
  • Dr Jacqueline Cumming
    Victoria University of Wellington
    Improving health system performance: an economic analysis of primary care reform
    $522,913
    36 months
  • Dr Jacqueline Cumming
    Victoria Link Limited
    Equity, variation and convergence in surgeons' clinical judgements of priority
    $1,093,031
    36 months
  • Professor Jackie Cumming
    Victoria University of Wellington
    Exploring the development and impact of changes in community pharmacy services
    $1,185,380
    42 months
  • Professor Jacqueline Cumming
    Victoria University of Wellington
    Integrated services to improve the health of Pacific peoples
    $1,194,152
    42 months
  • Professor Christopher Cunningham
    Massey University, Wellington
    Me Mutu Kai Paipa - Improving the provision of cessation to New Zealand smokers
    $577,719
    24 months
  • Dr Elana Curtis
    University of Auckland
    Examining emergency department inequities: do they exist?
    $899,943
    24 months
  • Associate Professor Maurice Curtis
    The University of Auckland
    Identifying the first signs of dementia in humans
    $891,792
    36 months
  • Professor Wayne Cutfield
    The University of Auckland
    Assessment of pituitary function following traumatic brain injury in infancy
    $616,770
    24 months
  • Professor Steven Dakin
    The University of Auckland
    Measuring visual field loss in glaucoma using involuntary eye movements
    $1,184,344
    36 months
  • Professor Nicola Dalbeth
    The University of Auckland
    Transitions to gout research (TIGER) study
    $1,196,151
    36 months
  • Dr Stuart Dalziel
    Auckland District Health Board
    RCT of Levetiracetam vs. Phenytoin for Status Epilepticus in Children
    $1,198,986
    36 months
  • Professor Stuart Dalziel
    Auckland DHB
    How safe are our emergency departments? A national prospective cohort study
    $1,197,164
    36 months
  • Professor Brian Darlow
    University of Otago, Christchurch
    New Zealand Very Low Birthweight Young Adults: Mapping the Road Ahead
    $1,150,400
    36 months
  • Associate Professor Alan Davidson
    The University of Auckland
    Understanding kidney injury and the role of HNF1beta
    $884,664
    36 months
  • Associate Professor Alan Davidson
    The University of Auckland
    Understanding how WT1 and its binding partner WTX cause renal disease
    $1,171,726
    36 months
  • Associate Professor Alan Davidson
    The University of Auckland
    The role of the Pax-Notch pathway in kidney disease
    $1,067,513
    36 months
  • Associate Professor Alan Davidson
    University of Auckland
    Kidney organoids: Modelling kidney injury and preclinical drug testing
    $1,182,356
    36 months
  • Dr Joanne Davidson
    The University of Auckland
    Look before we leap: strategies for treating mild neonatal encephalopathy
    $1,185,478
    36 months
  • Professor Peter Davis
    The University of Auckland
    Improving health systems performance: enhancing hopsital outcomes
    $1,727,442
    48 months
  • Professor Peter Davis
    The University of Auckland
    Life-course predictors of mortality inequalities
    $1,091,258
    36 months
  • Associate Professor Catherine Day
    University of Otago, Dunedin
    Uncovering how inhibitor of apoptosis proteins regulate cell survival
    $991,988
    36 months
  • Professor Catherine Day
    University of Otago, Dunedin
    Integration of inflammatory signalling by TNF receptor associated factors
    $1,185,038
    36 months
  • Dr Martin de Bock
    University of Otago
    Automated insulin delivery for type 1 diabetes utilising open source technology
    $1,317,623
    36 months
  • Dr Janak de Zoysa
    Waitemata District Health Board
    CKD-FIX: Trial of xanthine oxidase inhibition to slow kidney disease progression
    $990,685
    48 months
  • Dr Justin Dean
    University of Auckland
    Targeting IGF-1 signalling for repair of preterm brain dysmaturation
    $1,157,670
    36 months
  • Professor William Denny
    The University of Auckland
    Dual activation of anticancer prodrugs by hypoxia and reductase-armed adenovirus
    $1,150,069
    36 months
  • Professor William Denny
    University of Auckland
    Development of a novel and specific inhibitor of CSF1R for cancer therapy
    $1,199,967
    36 months
  • Associate Professor Sarah Derrett
    Massey University, Palmerston North
    Subsequent Injury Study (SInS): Improving outcomes for injured New Zealanders
    $588,676
    24 months
  • Professor Sarah Derrett
    University of Otago
    Prospective Outcomes of Injury Study: 10 years on (POIS-10)
    $1,193,001
    36 months
  • Dr Ofa Dewes
    University of Auckland
    Differences in fructose uptake in Pacific adolescents
    $599,987
    36 months
  • Associate Professor Paul Donaldson
    The University of Auckland
    Diabetic lens cataract: a problem with cell volume regulation
    $1,302,476
    36 months
  • Professor Paul Donaldson
    The University of Auckland
    Delivering lens anti-oxidants: A strategy to develop anti-cataract therapies
    $1,198,171
    36 months
  • Professor Robert Doughty
    The University of Auckland
    International Relationship Fund: EU-NZ collaboration
    $199,951
    24 months
  • Professor Robert Doughty
    The University of Auckland
    Biomarker-guided secondary prevention post-acute coronary syndromes: An RCT
    $1,596,636
    36 months
  • Professor Jeroen Douwes
    Massey University, Wellington
    Building Research in Occupational Health in New Zealand (BROHNZ)
    $2,812,901
    36 months
  • Professor Jeroen Douwes
    Massey University, Wellington
    Unpasteurised Milk: Protective for Allergies and Asthma?
    $1,199,899
    36 months
  • Professor Jeroen Douwes
    Massey University, Wellington
    Pesticide exposure and neuropsychological effects in children
    $1,198,428
    36 months
  • Professor Jeroen Douwes
    Massey University, Wellington
    Non-inflammatory mechanisms in asthma
    $1,199,966
    36 months
  • Professor Jeroen Douwes
    Massey University, Wellington
    Persistent airflow limitation and the airway microbiome in childhood asthma
    $1,199,980
    48 months
  • Professor Jeroen Douwes
    Massey University, Wellington
    Work-related risk factors for cardiovascular disease
    $715,281
    24 months
  • Professor Jeroen Douwes
    Massey University
    Biodiversity and microbiota: A novel pathway to allergy and asthma prevention
    $1,199,961
    48 months
  • Professor Susan Dovey
    University of Otago, Dunedin
    Patient harms in New Zealand general practices: Records review study
    $1,174,690
    36 months
  • Professor Tony Dowell
    University of Otago, Wellington
    Understanding diabetes management: tracking communication in primary care
    $1,125,164
    24 months
  • Dr Margaret Dudley
    University of Auckland
    A Māori approach to the assessment and management of dementia
    $1,056,270
    48 months
  • Associate Professor Rod Dunbar
    The University of Auckland
    Antigen presentation to T cells in human lymph nodes
    $991,603
    36 months
  • Associate Professor Rod Dunbar
    The University of Auckland
    Targeting vaccines to human antigen-presenting cells with synthetic glycopeptides
    $1,104,583
    36 months
  • Professor Rod Dunbar
    University of Auckland
    Targeting cancer vaccines to human dendritic cells via CD301
    $1,190,835
    36 months
  • Professor Rod Dunbar
    University of Auckland
    Proliferating tumour-associated macrophages in human cancers
    $1,173,502
    36 months
  • Dr Scott Duncan
    AUT University
    Healthy Homework: A physical activity and nutrition intervention for children
    $1,187,412
    36 months
  • Professor Michael Eccles
    University of Otago, Dunedin
    Epigenomic profiling to predict patient response to melanoma immunotherapy
    $1,198,714
    36 months
  • Professor Richard Edwards
    University of Otago, Wellington
    The New Zealand International tobacco control project
    $1,199,957
    48 months
  • Dr Lis Ellison-Loschmann
    Massey University
    Māori and Cancer - the Role of Primary Care
    $574,465
    36 months
  • Dr Lis Ellison-Loschmann
    Massey University
    Inequalities in cervical cancer survival in New Zealand
    $665,198
    36 months
  • Dr Lis Ellison-Loschmann
    Massey University
    Stomach cancer in Māori
    $951,381
    60 months
  • Dr Lis Ellison-Loschmann
    Massey University
    Understanding the determinants of inequalities in breast cancer survival
    $1,004,153
    36 months
  • Dr Lis Ellison-Loschmann
    Massey University
    Cancer support programmes for Māori whānau
    $1,036,429
    36 months
  • Dr Jeffrey Erickson
    University of Otago, Dunedin
    CaMKII inhibition as a novel therapy for diabetic cardiomyopathy
    $1,046,772
    36 months
  • Dr Daniel Exeter
    The University of Auckland
    Delivering a new measure of neighbourhood disadvantage for New Zealand
    $1,104,296
    36 months
  • Dr Ausaga Faaselele Tanuvasa
    Victoria University of Wellington
    Exploring Samoan women's attitudes towrads antenatal and midwifery care
    $303,331
    36 months
  • Dr Allamanda Faatoese
    University of Otago
    Environmental effects on cardiometabolic biomarkers in Pacific peoples
    $594,804
    36 months
  • Professor Valery Feigin
    AUT University
    Extension to the Traumatic Brain Injury Burden in New Zealand Study
    $345,465
    14 months
  • Professor Valery Feigin
    AUT University
    Traumatic brain injury burden in NZ: a population-based incidence & outcomes
    $2,366,538
    36 months
  • Associate Professor Valery Feigin
    Auckland UniServices Ltd
    Long-term functional and neuropsychological outcomes after stroke in New Zealand
    $1,015,021
    36 months
  • Professor Valery Feigin
    AUT University
    Long-term impact of initial and recurrent traumatic brain injury (TBI) in the NZ community
    $1,192,250
    36 months
  • Dr Theresa Fleming
    Victoria University of Wellington
    Integrating survey and intervention research for youth health gains
    $1,189,388
    36 months
  • Professor John Fraser
    The University of Auckland
    The role of superantigen-like toxins in staphylococcal disease
    $1,283,262
    36 months
  • Professor John Fraser
    University of Auckland
    A vaccine to limit the severity of staphylococcal infections
    $1,048,945
    36 months
  • Associate Professor Mhoyra Fraser
    The University of Auckland
    New horizons for preterm brain protection: exploiting endogenous neuroprotection
    $1,187,296
    36 months
  • Professor Nigel French
    Massey University, Palmerston North
    Is the family pet a risk factor for multidrug resistant bacterial infections?
    $1,126,725
    36 months
  • Professor Philippa Gander
    Massey University, Wellington
    Implementing a science-based approach for fatigue risk management in nursing
    $890,523
    36 months
  • Associate Professor Edward Gane
    Auckland District Health Board
    Can Better Surveillance Prevent Liver Cancer and Death in Maori with Chronic HBV
    $964,393
    30 months
  • Professor Edward Gane
    Auckland District Health Board
    Molecular predictors of liver cancer in Māori with chronic hepatitis B
    $529,899
    24 months
  • Dr Heather Gifford
    Whakauae Research Services
    Māori Nurses and Smoking - Exploring the Context and Opportunity for Change
    $594,506
    24 months
  • Dr Heather Gifford
    Whakauae Research Services Limited, Whanganui
    Preventing chronic conditions: Learnings from participatory research with Māori
    $1,199,647
    36 months
  • Professor Michelle Glass
    University of Otago
    Characterisation of synthetic cannabinoid signalling bias and toxicity
    $1,172,581
    36 months
  • Dr Elspeth Gold
    University of Otago, Dunedin
    Role of activin C in prostate disease
    $953,695
    36 months
  • Ms Delvina Gorton
    The University of Auckland
    The effects of a school breakfast programme on school achievement and nutrition
    $810,753
    24 months
  • Professor Merryn Gott
    The University of Auckland
    Pakeketanga: Living and dying in advanced age
    $1,191,255
    36 months
  • Associate Professor Cameron Grant
    The University of Auckland
    Randomised placebo controlled study of vitamin D during pregnancy and infancy
    $958,341
    30 months
  • Associate Professor Cameron Grant
    University of Auckland
    Effect of early childhood ear infections on language, cognition and behavior
    $1,191,663
    36 months
  • Associate Professor David Grattan
    University of Otago, Dunedin
    Mechanisms of hyperprolactinemia-induced infertility
    $949,105
    36 months
  • Professor David Grattan
    University of Otago, Dunedin
    Role of kisspeptin in hyperprolactinemia-induced infertility
    $1,164,184
    36 months
  • Professor David Grattan
    University of Otago, Dunedin
    Role of hypothalamic beta-catenin in body weight regulation
    $1,195,099
    36 months
  • Dr Katie Groom
    The University of Auckland
    STRIDER (NZAus): RCT of sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction (IUGR)
    $1,147,306
    36 months
  • Associate Professor Parry Guilford
    University of Otago, Dunedin
    Synthetic lethal Targeting of the Tumour Suppressor Gene CDH1 in Common Cancers
    $1,080,001
    36 months
  • Associate Professor Parry Guilford
    University of Otago, Dunedin
    Single Cell RNA Profiling for the Early Detection of Urological Cancers
    $820,303
    36 months
  • Professor Parry Guilford
    University of Otago, Dunedin
    The chemoprevention and treatment of diffuse gastric cancer
    $1,189,286
    36 months
  • Professor Alistair Gunn
    The University of Auckland
    Protecting brain development after clinically silent infection before birth
    $1,151,828
    36 months
  • Professor Leigh Hale
    University of Otago, Dunedin
    Community exercise for long-term management of diabetes and multimorbidity
    $1,181,772
    36 months
  • Professor Leigh Hale
    University of Otago, Dunedin
    Co-creating a digital self-help intervention for people with persistent pain
    $1,198,177
    36 months
  • Associate Professor Simon Hales
    University of Otago
    Climate change, extreme rainfall events and enteric disease outbreaks
    $1,190,579
    36 months
  • Dr Christopher Hall
    University of Auckland
    Targeting crystal-driven macrophage activation to suppress gouty inflammation
    $1,185,170
    36 months
  • Dr Mark Hampton
    University of Otago, Christchurch
    Peroxiredoxins in antioxidant defence and cell signalling
    $1,520,054
    36 months
  • Dr Robert Hancox
    University of Otago, Dunedin
    The Dunedin Next Generation Studies
    $1,850,398
    60 months
  • Associate Professor Bob Hancox
    University of Otago, Dunedin
    The next generation studies
    $1,195,331
    36 months
  • Professor Bob Hancox
    University of Otago
    A randomised controlled trial of beta-blockers in COPD
    $1,439,384
    60 months
  • Professor Jane Harding
    The University of Auckland
    Neonatal Hypoglycaemia: How do we know how low is too low?
    $1,061,608
    36 months
  • Professor Jane Harding
    The University of Auckland
    Childhood outcomes after exposure to repeat doses of antenatal corticosteriods
    $898,510
    36 months
  • Professor Jane Harding
    The University of Auckland
    Preventing neonatal hypoglycaemia with oral dextrose gel
    $1,197,340
    36 months
  • Professor Jane Harding
    The University of Auckland
    Does preventing neonatal hypoglycaemia improve outcome at two years of age?
    $1,599,837
    60 months
  • Professor Jane Harding
    University of Auckland
    Mid-childhood outcomes of children born at risk of neonatal hypoglycaemia
    $1,198,903
    36 months
  • Professor Jane Harding
    The University of Auckland
    Nutrition and brain development in moderate and late preterm babies
    $1,187,239
    36 months
  • Dr Ricci Harris
    University of Otago
    Racism as a health determinant: implications for Māori health and inequalities
    $600,032
    36 months
  • Dr Ricci Harris
    University of Otago, Dunedin
    Understanding the impact of racial discrimination on adult health and wellbeing
    $452,778
    36 months
  • Dr Gavin Harris
    Canterbury District Health Board
    Using deep learning and digital pathology to intrinsically subtype breast cancer
    $249,650
    24 months
  • Dr Deborah Hay
    The University of Auckland
    Adrenomedullin 1 receptor antagonists as novel anti-angiogenic agents
    $1,199,853
    36 months
  • Associate Professor Michael Hay
    University of Auckland
    Novel radiosensitisers for head and neck cancer
    $1,198,115
    36 months
  • Associate Professor Michael Hay
    The University of Auckland
    Doubling down on DNA-PK: Radiosensitisers for head and neck cancer
    $1,199,999
    36 months
  • Associate Professor Anne-Louise Heath
    University of Otago
    Novel methods of infant feeding in New Zealand - cause for concern or optimism?
    $1,185,359
    36 months
  • Associate Professor Nuala Helsby
    University of Auckland
    Can pre-screening reduce the risk of life-threatening fluoropyrimidine toxicity?
    $1,186,557
    36 months
  • Professor Allan Herbison
    University of Otago, Dunedin
    Understanding Kisspeptin Neurons
    $1,002,385
    36 months
  • Professor Allan Herbison
    University of Otago
    Calcium oscillations in GnRH neurons
    $1,084,086
    36 months
  • Professor Peter Herbison
    University of Otago, Dunedin
    Advanced Meta-analysis
    $970,247
    36 months
  • Professor Alan Herbison
    University of Otago, Dunedin
    Generating pulses with KNDy neurons
    $1,121,058
    36 months
  • Professor Allan Herbison
    University of Otago, Dunedin
    Deciphering the dendron for fertility control
    $1,092,337
    36 months
  • Professor Allan Herbison
    University of Otago, Dunedin
    GnRH neuron control of ovulation
    $1,167,633
    36 months
  • Dr Ian Hermans
    Malaghan Institute of Medical Research
    Mechanisms of induction of anti-tumour immune responses by dendritic cells
    $933,049
    36 months
  • Dr Ian Hermans
    Malaghan Institute of Medical Research
    Increasing the potency of dendritic cell based vaccines for treatment of cancer
    $562,623
    36 months
  • Associate Professor Ian Hermans
    Malaghan Institute of Medical Research
    Vaccination and immunomodulation: Creating effective therapy for cancer
    $1,190,900
    36 months
  • Associate Professor Ian Hermans
    Malaghan Institute of Medical Research
    Synthetic vaccines that exploit the innate immune response
    $1,192,956
    36 months
  • Dr Merilyn Hibma
    University of Otago
    Regulation of host defences in the skin by a tumour-causing virus
    $981,217
    36 months
  • Dr Nancy Higgins
    Ngāti Kāpo O Aotearoa Inc
    Growing up kapo Māori: Accessing paediatric opthalmology services
    $501,216
    24 months
  • Dr Nancy Higgins
    Donald Beasley Institute
    Working in intellectual disability services: Staff retention and turnover
    $1,137,610
    36 months
  • Dr Nancy Higgins
    Donald Beasley Institute
    Growing up kapo Māori: Whanau, identity, cultural well-being and health
    $389,589
    24 months
  • Professor Andrew Hill
    University of Auckland
    Development and application of a risk prediction tool for emergency laparotomy
    $1,181,513
    42 months
  • Professor Janet Hoek
    University of Otago, Dunedin
    Evaluating branding and plain packaging: Implications for tobacco control
    $740,727
    36 months
  • Professor Janet Hoek
    University of Otago, Dunedin
    SMIRQ: Smokefree Messages: Interpretations, Responses and Quitting
    $503,000
    36 months
  • Professor Janet Hoek
    University of Otago, Dunedin
    Supporting informed e-cigarette use: A mixed methods study
    $1,196,668
    36 months
  • Professor Janet Hoek
    University of Otago
    Developing optimal strategies to support smoking cessation among RYO users
    $1,195,934
    36 months
  • Associate Professor Julia Horsfield
    University of Otago, Dunedin
    Investigating a novel drug target in acute myeloid leukaemia
    $1,147,327
    36 months
  • Associate Professor Julia Horsfield
    University of Otago
    A novel genetic mechanism in acute myeloid leukaemia
    $1,177,919
    36 months
  • Mr Maui Hudson
    Institute of Environmental Science & Research Ltd
    Nga Tohu o te Ora: traditional Māori wellness outcome measures
    $699,370
    36 months
  • Mr Maui Hudson
    University of Waikato
    Building BRIDGES for Culturally Ethical Biobanking and Genomic Research
    $1,141,547
    36 months
  • Dr Ben Hudson
    University of Otago, Dunedin
    A randomised controlled trial of nortriptyline in knee osteoarthritis
    $1,190,921
    36 months
  • Associate Professor Stephanie Hughes
    University of Otago
    Dissecting the role of glial lysosome function in neurodegeneration
    $1,199,417
    36 months
  • Ms Gayl Humphrey
    The University of Auckland
    Smart phone delivered CBT for gambling related harm: An RCT
    $1,190,695
    36 months
  • Associate Professor Brian I Hyland
    University of Otago
    Neurophysiological basis of a novel drug treatment for Parkinson's disease
    $889,668
    36 months
  • Associate Professor Brian Hyland
    University of Otago, Dunedin
    Restoring Thalamocortical Activity to Treat Parkinson's Disease Symptoms
    $1,166,489
    42 months
  • Dr Tristram Ingham
    University of Otago, Wellington
    Whiti Te Ra: The Contribution of Housing Conditions to Bronchiolitis Disparities
    $1,157,725
    36 months
  • Dr Tristram Ingham
    University of Otago
    Whiti Te Ra: Bronchiolitis Disparities among Māori and Pacific Children
    $1,146,720
    36 months
  • Dr Tristram Ingham
    University of Otago, Wellington
    Whakapai e te Ara Hā: A health literacy approach to tamariki asthma
    $1,199,724
    36 months
  • Dr Karl Iremonger
    University of Otago
    A neural circuit to suppress stress in motherhood
    $1,167,222
    36 months
  • Associate Professor Keith Ireton
    University of Otago, Dunedin
    Role of host exocytosis in infection of human cells by Listeria monocytogenes
    $932,485
    36 months
  • Dr Anne-Marie Jackson
    University of Otago
    Tangaroa Ara Rau: Māori water safety programme for whānau
    $1,192,263
    36 months
  • Associate Professor Micahel Jameson
    The University of Auckland
    More gain, less pain from chemoradiation for rectal cancer by adding simvastatin
    $1,399,054
    60 months
  • Dr Hamish Jamieson
    University of Otago, Christchurch
    Using the InterRAI to improve identification and management of frailty
    $1,167,728
    36 months
  • Dr Stephen Jamieson
    The University of Auckland
    Precision treatment of head and neck cancer with evofosfamide
    $1,199,967
    36 months
  • Dr Rhys Jones
    The University of Auckland
    Marae Food Gardens: Health and Wellbeing through the Urban Marae in Tamaki Makaurau
    $1,165,597
    36 months
  • Dr Peter Jones
    Auckland District Health Board
    Implementing performance improvement in New Zealand Emergency Departments: the six hour time target policy
    $1,138,171
    36 months
  • Ms Bernadette Jones
    University of Otago
    Pukapuka Hauora: Parents knowledge of preventing and treating their child's asthma
    $624,415
    24 months
  • Ms Bernadette Jones
    University of Otago, Wellington
    He kura: Asthma support for Maori tamariki at school
    $1,199,064
    36 months
  • Associate Professor Gregory Jones
    University of Otago, Dunedin
    An epigenome-wide study for abdominal aortic aneurysm
    $1,138,354
    36 months
  • Associate Professor Greg Jones
    University of Otago, Dunedin
    An epigenome-wide study for coronary artery disease
    $1,139,534
    36 months
  • Dr Kelly Jones
    AUT University
    Reducing fatigue after stroke: A randomised controlled trial 36 months, $1,188,578
    $1,188,578
    36 months
  • Dr Peter Jones
    University of Otago, Dunedin
    A novel target for the control of arrhythmias
    $1,133,212
    36 months
  • Mrs Bernadette Jones
    University of Otago
    Te Ao Mārama: Disability perspectives of tāngata whaikaha Māori
    $1,186,338
    36 months
  • Associate Professor Andrew Jull
    The University of Auckland
    Low dose aspirin for venous leg ulcers: A randomised trial
    $1,199,722
    36 months
  • Associate Professor Andrew Jull
    University of Auckland
    Keramatrix4VLU: a trial of wool-derived keratin dressings for venous ulcers
    $1,199,977
    36 months
  • Professor Andrew Jull
    The University of Auckland
    Exercise or hypochlorous acid for venous leg ulcer healing: Factorial4VLU trial
    $1,402,941
    36 months
  • Associate Professor Nicola Kayes
    AUT University
    Evaluating a sustainable model of peer mentoring in traumatic brain injury
    $1,192,532
    36 months
  • Dr Michael Keall
    University of Otago, Wellington
    Safety on steps: a randomised controlled trial
    $1,199,815
    48 months
  • Associate Professor Martin Kennedy
    University of Otago
    Pharmacogenomics of antidepressant drugs
    $682,555
    36 months
  • Professor Martin Kennedy
    University of Otago, Christchurch
    Genomic analysis of adverse drug reactions
    $1,186,141
    36 months
  • Professor Ngaire Kerse
    The University of Auckland
    Life and Living in Advanced age: a Cohort study in New Zealand, (LILACS NZ): Waves 2 and 3
    $1,200,000
    36 months
  • Professor Ngaire Kerse
    The University of Auckland
    Staying UpRight in residential care
    $1,443,303
    36 months
  • Professor Anthony Kettle
    University of Otago, Christchurch
    Oxidative stress in cystic fibrosis
    $801,555
    36 months
  • Dr Bronwyn Kivell
    Victoria University of Wellington
    Development of novel remyelination treatments for multiple sclerosis
    $1,167,846
    36 months
  • Dr Bridget Kool
    The University of Auckland
    Prehospital injury deaths: preventability, service accessibility and equity
    $598,181
    24 months
  • Associate Professor Bridget Kool
    The University of Auckland
    Evaluating the impact of prehospital care on mortality following major trauma
    $1,096,497
    30 months
  • Professor Jane Koziol-McLain
    AUT University
    Internet-based Intervention to Improve Mental Health Outcomes for Abused Women
    $1,187,960
    60 months
  • Professor Kurt Krause
    University of Otago
    New drugs for the post-antibiotic era by targeting glutamate racemase
    $1,199,914
    36 months
  • Dr Jeremy Krebs
    University of Otago
    Diabetes excess weight loss (DEWL) trial: High protein vs low fat diets
    $1,461,278
    36 months
  • Dr Kypros Kypri
    University of Otago, Dunedin
    Effects of Lowering the Minimum Alcohol Purchasing Age on Traffic Crash Injury and Assault Rates
    $263,908
    24 months
  • Dr Cameron Lacey
    University of Otago, Christchurch
    Māori and bipolar disorder
    $1,181,030
    36 months
  • Dr Cameron Lacey
    University of Otago, Christchurch
    Pathways to First Episode Psychosis and Outcomes In Māori
    $618,336
    24 months
  • Professor Iain Lamont
    University of Otago, Dunedin
    Unmasking genes for antibiotic resistance in a superbug
    $1,151,504
    36 months
  • Professor Ross Lawrenson
    The University of Auckland
    How to improve outcomes for women with breast cancer in New Zealand
    $1,175,663
    36 months
  • Professor Ross Lawrenson
    University of Waikato
    Improving early access to lung cancer diagnosis for Māori and rural communities
    $1,194,260
    36 months
  • Professor Ross Lawrenson
    University of Waikato
    Reducing delay and increasing access to early diagnosis for colorectal cancer
    $1,195,378
    36 months
  • Dr Beverley Lawton
    University of Otago
    Addressing barriers to care for young pregnant Māori women and their infants
    $1,199,936
    36 months
  • Dr Beverley Lawton
    University of Otago, Wellington
    Wāhine Hauora-Inequalities in uterine cancer: exploring the pre-diagnosis gap
    $707,474
    30 months
  • Dr Beverley Lawton
    University of Otago, Wellington
    Diabetes -The Impact of Maternal Care Disparities on Māori Mothers and Infants
    $1,192,365
    36 months
  • Dr Beverley Lawton
    University of Otago, Wellington
    Wahine hauora: reducing barriers to care for pregnant mums and their whanau
    $1,179,945
    48 months
  • Dr Beverley Lawton
    University of Otago, Wellington
    Addressing the burden and preventability of severe acute maternal morbidity
    $1,199,906
    36 months
  • Associate Professor Beverly Lawton
    University of Otago, Dunedin
    Addressing avoidable harm suffered by Māori babies
    $1,199,999
    36 months
  • Associate Professor Beverley Lawton
    University of Otago
    He Tapu Te Whare Tangata
    $1,194,662
    36 months
  • Professor Beverley Lawton
    Victoria University of Wellington
    Whānau Manaaki: Methamphetamines - a strength-based community approach
    $1,187,031
    36 months
  • Professor Graham Le Gros
    Malaghan Institute of Medical Research, Wellington
    Cellular Mechanisms Underlying Food Allergen Sensitisation
    $1,186,852
    36 months
  • Professor Graham Le Gros
    Malaghan Institute of Medical Research
    Novel vaccine approaches for protecting against helminth parasites
    $1,199,319
    36 months
  • Professor Graham Le Gros
    Malaghan Institute of Medical Research
    Candidate Cytokines involved in Allergic Airway disease
    $1,029,696
    36 months
  • Dr Rebbecca Lilley
    University of Otago, Dunedin
    Creating safer workplaces: understanding our work-related fatalities
    $1,191,876
    36 months
  • Dr Judith Littleton
    The University of Auckland
    Transnationalism in Pacific health through the lens of TB
    $1,411,510
    36 months
  • Dr Denis Loiselle
    The University of Auckland
    Energetics of the Diabetic Heart
    $1,009,179
    36 months
  • Dr Andrew Macann
    Auckland District Health Board
    Chemoradiotherapy vs radiotherapy in high risk cutaneous squamous cell carcinoma
    $123,562
    36 months
  • Dr Peter Mace
    University of Otago, Dunedin
    Role of the Trib1 pseudokinase in breast cancer pathology
    $1,128,825
    36 months
  • Dr Peter Mace
    University of Otago, Dunedin
    Understanding regulation of the polycomb-repressive deubiquitinase in malignancy
    $1,193,468
    36 months
  • Dr Brett MacLennan
    University of Otago, Dunedin
    Evaluation of New Zealand's alcohol reform legislation
    $1,190,521
    48 months
  • Dr Alexandra Macmillan
    The University of Auckland
    Health effects of intervening in the trip to work
    $428,497
    36 months
  • Dr Alex Macmillan
    University of Otago
    Health and equity impacts of Te Ara Mua Future Streets
    $1,185,793
    30 months
  • Dr Ralph Maddison
    The University of Auckland
    Efficacy of an m-health exercise-based cardiac rehabilitation programme
    $1,158,387
    36 months
  • Dr Ralph Maddison
    The University of Auckland
    Exercise to enhance smoking cessation outcomes
    $1,343,716
    36 months
  • Professor Ralph Maddison
    The University of Auckland
    Rugby fans in training: A randomised controlled trial
    $1,199,266
    36 months
  • Associate Professor Simon Malpas
    The University of Auckland
    Development of wireless power for an implantable heart pump
    $1,183,070
    36 months
  • Professor Simon Malpas
    The University of Auckland
    Improving hydrocephalus management through an implantable device
    $1,188,597
    36 months
  • Associate Professor Sandra Mandic
    University of Otago
    Built environment and active transport to school: BEATS natural experiment
    $1,197,487
    36 months
  • Professor Jim Mann
    University of Otago
    Lifestyle over and above drugs in diabetes (LOADD) study
    $669,075
    24 months
  • Associate Professor Patrick Manning
    University of Otago, Dunedin
    Does Cabergoline Prevent Weight Regain in People with Obesity
    $1,192,020
    48 months
  • Dr Mark Marshall
    Counties Manukau District Health Board, Auckland
    Sodium Lowering in Dialysate (SOLID) Study
    $1,170,074
    36 months
  • Dr Mark Marshall
    Centre for Clinical Research and effective practice
    Myocardial microinjury and arterial compliance in the SOLID trial (Mac-SOLID)
    $254,016
    36 months
  • Dr Mark Marshall
    Middlemore Clinical Trials
    Pragmatic clinical trial of sodium lowering in dialysate
    $1,199,044
    60 months
  • Dr Colin McArthur
    Auckland District Health Board
    Randomised evaluation of normal vs augmented level renal replacement therapy
    $187,900
    24 months
  • Dr Colin McArthur
    Auckland District Health Board
    Standard Issue Transfusion versus Fresher Red Blood Cell Use in Intensive Care
    $775,723
    36 months
  • Dr Colin McArthur
    Auckland District Health Board
    Randomised Trial of Hydrocortisone in Critically Ill Patients with Septic Shock
    $773,854
    48 months
  • Dr Colin McArthur
    Auckland District Health Board
    RCT of continuous vs intermittent beta-lactam antibiotics in the critically ill
    $213,894
    24 months
  • Dr Colin McArthur
    Auckland District Health Board
    Early goal-directed sedation in mechanically ventilated intensive care patients
    $1,118,621
    48 months
  • Dr Colin McArthur
    Medical Research Institute of New Zealand
    Pre-hospital anti-fibrinolytics for traumatic coagulopathy and haemorrhage
    $943,384
    36 months
  • Dr Colin McArthur
    Medical Research Institute of New Zealand
    Bacteraemia antibiotic length actually needed for clinical effectiveness-BALANCE
    $1,191,322
    48 months
  • Dr Kirsten McAuley
    University of Otago
    Determining optimal approachs for successful maintenance of weight loss
    $533,445
    36 months
  • Dr Fiona McBryde
    The University of Auckland
    Hypertension after stroke - therapeutic or pathological?
    $1,055,738
    36 months
  • Dr Melanie-Jane McConnell
    Victoria University of Wellington
    Mitochondrial injury and inter-cellular mitochondrial transfer
    $1,036,746
    36 months
  • Dr Sally McCormick
    University of Otago
    Regulation of HDL levels
    $665,680
    36 months
  • Associate Professor Sally McCormick
    University of Otago, Dunedin
    Restoring high density lipoprotein levels
    $1,044,053
    36 months
  • Professor Sally McCormick
    University of Otago, Dunedin
    Targeting new receptors for lipoprotein(a)
    $1,185,496
    48 months
  • Professor Lesley McCowan
    The University of Auckland
    Multi-centre case control stillbirth study
    $544,777
    51 months
  • Dr Tim McCreanor
    Massey University
    Media, health and wellbeing in Aotearoa
    $813,650
    36 months
  • Dr Shay McGuinness
    Auckland District Health Board
    Permissive Hypercapnia, Alveolar Recruitment and Limited Airway Pressure in ARDS
    $320,961
    36 months
  • Dr Shay McGuinness
    Auckland District Health Board
    Restrictive vs liberal fluid therapy in major abdominal surgery - The RELIEF study
    $770,668
    36 months
  • Dr Shay McGuinness
    Medical Research Institute of New Zealand
    Transfusion requirements in patients for cardiac surgery - TRiCS III
    $1,199,468
    36 months
  • Dr Shay McGuinness
    Medical Research Institute of New Zealand
    Timing of initiation of renal support in acute kidney injury (STARRT-AKI)
    $1,191,467
    60 months
  • Dr Shay McGuinness
    Medical Research Institute of New Zealand
    BLING III - Phase III RCT of continuous β-lactam infusion in the critically ill
    $1,195,807
    60 months
  • Associate Professor Mark McKeage
    The University of Auckland
    Contribution of OCTN1 to Toxicity from Oxaliplatin-based Cancer Therapy
    $1,180,897
    36 months
  • Professor Mark McKeage
    The University of Auckland
    Lung cancer genetic testing in New Zealand
    $1,182,641
    36 months
  • Professor Mark McKeage
    The University of Auckland
    Reducing oxaliplatin toxicity: A randomised dose-finding proof-of-concept trial
    $1,195,454
    36 months
  • Professor Mark McKeage
    The University of Auckland
    Do concomitant medicines impede safe and effective lung cancer treatment in New Zealand?
    $1,194,776
    36 months
  • Dr David McLean
    Massey University
    Cancer in meat workers: identifying the causal exposures
    $1,199,183
    36 months
  • Professor Ian McLennan
    University of Otago, Dunedin
    Anti-Müllerian hormone regulation of female reproduction
    $1,169,771
    48 months
  • Professor Dr Neil McNaughton
    University of Otago, Dunedin
    Clinical translation of an anxiety process biomarker
    $1,040,728
    36 months
  • Dr Harry McNaughton
    Medical Research Institute of New Zealand
    Self-directed rehabilitation RCT after stroke: a practical, low-cost programme
    $1,199,802
    36 months
  • Professor Dr Neil McNaugton
    University of Otago
    Do hippocampus, insula and amygdala contribute to an anxiety syndrome biomarker?
    $1,090,630
    36 months
  • Professor Kathryn McPherson
    AUT University
    Experiences of recovery and adaptation after disabling traumatic brain injury
    $733,196
    36 months
  • Professor Kathryn McPherson
    AUT University
    Goals and self regulation skills in brain injury rehabilitation: an RCT
    $1,541,590
    36 months
  • Professor Kathryn McPherson
    AUT University and Auckland UniServices Ltd
    Improving health interventions and support for mothers experiencing disability
    $486,106
    27 months
  • Professor Kathryn McPherson
    AUT University
    Addressing barriers to physical activity in multiple sclerosis: a RCT
    $250,521
    12 months
  • Professor Kathryn McPherson
    AUT University
    Living well with a long term neurological condition
    $1,198,563
    48 months
  • Dr Kimberley Mellor
    University of Auckland
    Fructose and the heart: targeting novel mechanisms of diabetic cardiomyopathy
    $1,172,435
    36 months
  • Dr Kimberley Mellor
    The University of Auckland
    Glycotoxicity in the diabetic heart - novel treatment targets
    $1,148,222
    36 months
  • Dr Tony Merriman
    University of Otago
    The GRIK2 gene: A link between rheumatoid arthritis and schizophrenia?
    $878,896
    36 months
  • Professor Tony Merriman
    University of Otago
    Addressing clinical questions in gout using genetic data
    $1,198,120
    36 months
  • Professor Alan Merry
    The University of Auckland
    Multimodal, clinical assessment of a system to reduce error during anaesthesia
    $397,347
    18 months
  • Associate Professor Sally Merry
    The University of Auckland
    Modular evidence-based treatment of child and adolescent mental health problems
    $1,674,507
    36 months
  • Dr Troy Merry
    University of Auckland
    Understanding the role of insulin in promoting fatty liver disease
    $1,178,179
    36 months
  • Dr Troy Merry
    University of Auckland
    Targeting P13 to promote healthy ageing
    $1,186,059
    36 months
  • Dr Patricia Metcalf
    The University of Auckland
    Predictors of CVD morbidity and mortality in New Zealand adults
    $500,914
    24 months
  • Dr Patricia Metcalf
    The University of Auckland
    Determining the Health-related Impact of Dysglycaemia in a Local Population
    $385,630
    24 months
  • Dr Barry Milne
    University of Auckland
    Child poverty: health consequences, costs, and policy interventions
    $1,181,607
    36 months
  • Professor Edwin Mitchell
    The University of Auckland
    Children of SCOPE: The influence of fetal and maternal adiposity on obesity at 5
    $1,059,101
    36 months
  • Professor Edwin Mitchell
    The University of Auckland
    Sudden Unexpected Death in Infancy (SUDI): Nationwide Case-control Study
    $1,180,131
    36 months
  • Associate Professor Alok Mitra
    The University of Auckland
    Structure/function correlates of adiponectin
    $742,919
    36 months
  • Associate Professor Alok Mitra
    University of Auckland
    Targeting the ERp44-adiponectin interaction for diabesity treatment
    $1,188,969
    36 months
  • Dr Tess Moeke-Maxwell
    University of Auckland
    Pae Herenga: An investigation of Māori whānau end of life cultural care customs
    $1,198,828
    36 months
  • Associate Professor Helen Moewaka Barnes
    Massey University, Auckland
    Maori health identities: Affecting and driving health?
    $666,299
    36 months
  • Dr Brian Monk
    University of Otago, Dunedin
    Structure-directed antifungal discovery
    $1,190,954
    36 months
  • Associate Professor Brian Monk
    University of Otago, Dunedin
    Structure-directed discovery of next-generation antifungals
    $1,197,551
    36 months
  • Associate Professor Brian Monk
    University of Otago
    Readying next-generation antifungals for drug development
    $1,199,967
    36 months
  • Associate Professor Johanna Montgomery
    University of Auckland
    Targeting a zinc link in the treatment of Autism Spectrum Disorders
    $1,168,418
    36 months
  • Ms Kate Morgaine
    University of Otago, Dunedin
    Pilot intervention study to improve the oral health of rangatahi in Taranaki
    $100,000
    36 months
  • Professor Ian Morison
    University of Otago, Dunedin
    The epigenome of myelodysplastic syndrome
    $1,326,265
    36 months
  • Professor Roger Mulder
    University of Otago, Christchurch
    Health Anxiety CBT vs TAU for Patients with Non-Cardiac Chest Pain
    $726,684
    36 months
  • Professor David Murdoch
    University of Otago, Christchurch
    Effect of vitamin D supplementation on upper respiratory infections in adults
    $1,719,632
    30 months
  • Professor David Murdoch
    University of Otago, Dunedin
    Legionnaires' disease in New Zealand: Improving diagnostics and treatment
    $999,467
    30 months
  • Dr Suresh Muthukumaraswamy
    The University of Auckland
    Pharmacological brain-imaging of novel rapid antidepressant medicines
    $1,187,508
  • Dr Shyamala Nada-Raja
    University of Otago
    An internet-based CBT self-help for depression: a randomised controlled trial
    $1,222,946
    36 months
  • Professor Martyn Nash
    The University of Auckland
    Characterising heart failure with clinical imaging and structure-based modelling
    $1,183,076
    36 months
  • Dr Cliona Ni Mhurchu
    Auckland UniServices Ltd
    Strategies to promote healthier food purchases: a supermarket intervention trial
    $1,856,708
    36 months
  • Dr Garry Nixon
    University of Otago
    A rural-urban classification for New Zealand health research and policy
    $943,443
    30 months
  • Dr Pauline Norris
    University of Otago
    Equity in prescription medicines use
    $911,503
    36 months
  • Professor Tony Norris
    Massey University
    New Zealanders' attitudes towards access to Electronic Health Records
    $142,186
    12 months
  • Professor Pauline Norris
    University of Otago, Dunedin
    Randomised controlled trial of prescription charges
    $1,032,941
    36 months
  • Associate Professor Gregory O’Grady
    University of Auckland
    Translational advances in faecal incontinence and anterior resection syndrome
    $1,190,554
    36 months
  • Dr Melody Oliver
    AUT University
    Neighbourhoods for active kids
    $1,199,136
    36 months
  • Professor Gail Pacheco
    Auckland University of Technology
    Ethnic differences in the uptake of healthcare services: A microanalysis
    $1,088,386
    36 months
  • Dr Sarah-Jane Paine
    The University of Auckland
    Revealing the Realities of Racism for Rangatahi in Aotearoa - R4Aotearoa
    $1,197,117
    36 months
  • Professor Dr Suetonia Palmer
    University of Otago
    Serum phosphate to improve outcomes for dialysis patients: The PHOSPHATE trial
    $1,266,603
    60 months
  • Professor Dr Suetonia Palmer
    University of Otago
    Teaching to improve health outcomes for peritoneal dialysis: The TEACH-PD trial
    $1,439,326
    60 months
  • Dr Liping Pang
    Institute of Environmental Science & Research Ltd, Christchurch
    Community water supplies: ensuring microbial safety for disease prevention
    $1,061,133
    36 months
  • Associate Professor Rachael Parke
    Medical Research Institute of New Zealand
    Targeted therapeutic mild hypercapnia after resuscitated cardiac arrest
    $1,199,994
    48 months
  • Professor Emily Parker
    Victoria University of Wellington
    Tackling antimicrobial resistance
    $1,180,238
    36 months
  • Dr Lianne Parkin
    University of Otago, Dunedin
    Are treatments for COPD increasing the risk of acute coronary syndrome?
    $842,444
    36 months
  • Dr Louise Parr-Brownlie
    University of Otago, Dunedin
    Implantable light stimulator to treat Parkinson's disease
    $1,186,366
    36 months
  • Professor Janis Paterson
    AUT University
    Pacific Islands Families Study: nutrition, body size and physical activity of nine year old children (PIF:NBS-2)
    $898,178
    36 months
  • Professor Janis Paterson
    Auckland University of Technology
    Pacific Islands Families Study: Impact of hearing loss on Pacific youth
    $1,196,242
    36 months
  • Associate Professor Adam Patterson
    The University of Auckland
    Colonising tumour necrosis with Clostridium sporogenes for precision therapy
    $1,186,308
    36 months
  • Associate Professor Adam Patterson
    The University of Auckland
    Silencing oncogenic signalling in hypoxic tumour cells with the prodrug PR610
    $1,190,710
    36 months
  • Associate Professor Adam Patterson
    University of Auckland
    Development of an optimal hypoxia-selective cytotoxin for clinical use
    $1,194,356
    36 months
  • Associate Professor Adam Patterson
    The University of Auckland
    Banishing tumour hypoxia to render cancer immunotherapy curative
    $1,197,122
    36 months
  • Professor Neil Pearce
    Massey University
    Neurotoxic effects of occupational solvent exposure
    $1,199,985
    36 months
  • Dr Maria Pearse
    Auckland District Health Board
    Phase 3 trial studying optimal radiotherapy timing after radical prostatectomy
    $1,169,103
    60 months
  • Dr Chris Pemberton
    University of Otago, Christchurch
    Sending A Signal? Ghrelin Peptides in Acute Cardiac Ischemia
    $643,363
    36 months
  • Dr Chris Pemberton
    University of Otago, Christchurch
    BNP signal peptide: A novel, specific marker of acute cardiac injury
    $666,368
    36 months
  • Dr Chris Pemberton
    University of Otago, Christchurch
    Novel biomarker for acute coronary syndromes
    $1,164,058
    36 months
  • Dr Kyle Perrin
    Medical Research Institute of New Zealand
    RCT of invasive versus conservative treatment of pneumothorax
    $522,201
    36 months
  • Dr Ngaire Phillips
    National Institute of Water & Atmospheric Research
    Determining the contaminant health risk of kai moana, kai roto and kai awa
    $705,786
    36 months
  • Dr Richard Piet
    University of Otago, Dunedin
    Timekeeping in the neural network controlling fertility
    $1,074,371
    36 months
  • Dr Leonie Pihama
    University of Waikato
    He oranga ngākau: Māori and trauma informed care
    $1,190,130
    36 months
  • Dr Leonie Pihama
    University of Waikato
    Honour project Aotearoa
    $1,186,804
    36 months
  • Dr Anna Pilbrow
    University of Otago
    A precision medicine approach to improving heart disease outcomes
    $1,193,680
    36 months
  • Ms Suzanne Pitama
    University of Otago
    The Māori community heart study
    $1,919,504
    60 months
  • Professor Sally Poppitt
    The University of Auckland
    Seeking new insights and new routes to diabetes prevention: PREVIEW New Zealand
    $1,120,603
    36 months
  • Professor Richard Porter
    University of Otago
    Treating cognitive impairment in severe depression
    $1,151,916
    36 months
  • Professor John Potter
    Massey University, Wellington
    Self-sampling for HPV screening: a community trial
    $1,199,764
    36 months
  • Dr Tim Prickett
    University of Otago, Christchurch
    Studies on the cardio-protective effects of CNP agonists
    $646,169
    24 months
  • Dr Patricia Priest
    University of Otago, Dunedin
    Hand sanitiser to reduce illness absences in primary school children
    $797,205
    22 months
  • Associate Professor Thomas Proft
    The University of Auckland
    TeeVax - a novel vaccine against group A streptococcus?
    $1,122,354
    36 months
  • Dr Federik Pruijn
    The University of Auckland
    Molecular and Hypoxia Biomarkers of Sensitivity to New NitroCBI Anticancer Drugs
    $1,193,430
    36 months
  • Professor Andrew Pullan
    The University of Auckland
    New Clinical Tools for Diagnosing Gastric Dysfunction
    $1,114,289
    36 months
  • Professor Andrew Pullan
    The University of Auckland
    Mapping, Modelling and Manipulating Gastric Electrical Activity
    $1,303,066
    36 months
  • Associate Professor Miriam Rademaker
    University of Otago, Christchurch
    Implantable devices: Improved monitoring of heart failure and tachyarrhythmia
    $589,775
    36 months
  • Dr Rohit Ramchandra
    University of Auckland
    Physiological pacing to improve cardiac output in heart failure
    $1,115,696
    36 months
  • Dr Rohit Ramchandra
    The University of Auckland
    Targeting chemoreceptors in hypertension: a large animal pre-clinical trial
    $1,187,099
    36 months
  • Dr Annemarei Ranta
    University of Otago, Wellington
    Efficacy and Safety of TIA Electronic Support Tool (FASTEST) Trial
    $624,846
    24 months
  • Dr Annemarei Ranta
    University of Otago, Wellington
    Geographic and ethnic inequities in stroke outcomes
    $1,195,238
    36 months
  • Professor Steven Ratuva
    University of Canterbury
    Enrichment of community health through targeted social protection strategies
    $588,534
    36 months
  • Associate Professor Gordon Rewcastle
    The University of Auckland
    Strategies for developing PI3K p110α isoform specific anticancer drugs
    $1,498,525
    36 months
  • Dr Gordon W Rewcastle
    The University of Auckland
    PI3K inhibitors as targeted anticancer drugs
    $1,324,193
    36 months
  • Associate Professor Gordon Rewcastle
    The University of Auckland
    Targeted Cancer Drugs: a New Class of Selective Inhibitors of PI3 Kinase
    $1,199,179
    36 months
  • Dr Paul Reynolds
    Te Atawhai o Te Ao
    He kakano: Māori views and experiences of fertility, reproduction and ART
    $656,062
    36 months
  • Professor John Reynolds
    University of Otago
    Manipulating rewards to treat maladaptive brain disorders: Focus on tinnitus
    $1,192,994
    36 months
  • Professor Mark Richards
    University of Otago, Christchurch
    Urocortin2 in Decompensated Heart Failure
    $435,081
    24 months
  • Professor Mark Richards
    University Otago, Christchurch
    Renal denervation in heart failure with preserved ejection fraction
    $1,195,997
    36 months
  • Dr Rosalina Richards
    University of Otago
    Dr Rosalina Richards
    $577,528
    32 months
  • Professor Ann Richardson
    University of Otago, Christchurch
    Colorectal cancer control in New Zealand
    $1,397,629
    36 months
  • Professor Ann Richardson
    The University of Canterbury
    Breast cancer, cytomegalovirus, and Epstein-Barr virus
    $333,221
    24 months
  • Professor Stephen Robertson
    University of Otago, Dunedin
    Defining the genetic predisposition to biliary atresia
    $1,199,327
    36 months
  • Professor Stephen Robertson
    University of Otago, Dunedin
    Defining genetic regulators of neurogenesis in humans
    $1,185,630
    36 momths
  • Professor Stephen Robertson
    University of Otago, Dunedin
    Defining human specific genetic variants in brain developmental disorders
    $1,199,930
    36 months
  • Professor Franca Ronchese
    Malaghan Institute of Medical Research, Wellington
    Immunotherapy of Allergic Disease
    $1,170,798
    36 months
  • Professor Franca Ronchese
    Malaghan Institute of Medical Research
    Cytotoxic T lymphocyte-mediated immunotherapy of allergic airway inflammation
    $1,186,241
    36 months
  • Professor Franca Ronchese
    Malaghan Institute of Medical Research
    Role of dendritic cells in allergic sensitisation
    $1,023,152
    36 months
  • Professor Franca Ronchese
    Malaghan Institute of Medical Research
    Defining the characteristics of effective anti-tumour T cells
    $1,071,239
    36 months
  • Professor Franca Ronchese
    Malaghan Institute of Medical Research
    Manipulating antigen presentation to control disease
    $809,747
    36 months
  • Professor Franca Ronchese
    Malaghan Institute of Medical Research
    Role of Innate Cytokines in Allergic Dendritic Cell Programming
    $1,197,660
    36 months
  • Professor Franca Ronchese
    Malaghan Institute of Medical Research
    Conditioning dendritic cells for allergic immune responses
    $1,199,956
    36 months
  • Professor Franca Ronchese
    Malaghan Institute of Medical Research
    Monocyte-derived dendritic cells for tumour immunotherapy
    $1,199,993
    36 months
  • Professor Franca Ronchese
    Malaghan Institute of Medical Research
    Molecular characterisation of dendritic cells during immune responses
    $1,199,996
    36 months
  • Professor Elaine Rush
    AUT University
    Pacific Islands Families: Understanding growth from birth to fourteen years
    $1,171,911
    36 months
  • Dr Debbie Ryan
    Pacific Perspectives Limited
    Pacific patients' perspectives of treatment of chronic conditions
    $400,000
    24 months
  • Dr Lynette Sadleir
    University of Otago
    Defining the Genetic Determinants for Epilepsy
    $1,158,831
    36 months
  • Associate Professor Lynette Sadlier
    University of Otago, Wellington
    Gene discovery in epilepsy: the building block of precision medicine
    $1,198,069
    36 months
  • Dr Diana Sarfati
    University of Otago
    C3 study: Effect of comorbidity on care and cancer survival inequalities
    $1,171,238
    36 months
  • Associate Professor Diana Sarfati
    University of Otago, Dunedin
    Multimorbidity: The most common chronic condition of all
    $1,199,968
    36 months
  • Professor Philip Schluter
    AUT University
    Pacific Islands Families Study: Hearing Status of 11 year olds (PIF: HS)
    $732,717
    24 months
  • Associate Professor Grant Schofield
    AUT University
    Built environments, physical activity and obesity: A national and international study
    $1,128,187
    36 months
  • Professor Grant Schofield
    AUT University
    Built Environment and Physical Activity in New Zealand Youth
    $1,198,920
    36 months
  • Associate Professor Kate Scott
    University of Otago, Dunedin
    The Association of Mental Disorders with Subsequent Physical Condition Onsets
    $643,944
    36 months
  • Dr Kate Scott
    University of Otago, Wellington
    Double disability: mental disorders and comorbid physical conditions
    $154,576
    24 months
  • Dr Nina Scott
    Waikato District Health Board
    Does a Whānau Ora approach improve outcomes for hosptialised tamariki?
    $933,933
    36 months
  • Associate Professor Robert Scragg
    The University of Auckland
    Quantifying the association between sun exposure and vitamin D status in New Zealanders
    $1,731,317
    36 months
  • Professor Robert Scragg
    The University of Auckland
    Improving CVD risk prediction in primary care: novel arterial waveform method
    $1,199,504
    48 months
  • Dr Grant Searchfield
    University of Auckland
    Randomised controlled trial of hearing aids to improve cognition in older New Zealanders
    $1,150,909
    24 months
  • Dr Vanessa Selak
    The University of Auckland
    Aspirin harm benefit calculator to guide cardiovascular primary prevention
    $632,382
    24 months
  • Professor Douglas Sellman
    University of Otago, Christchurch
    Treatment Evaluation of Alcohol and Mood: The TEAM Study
    $840,037
    42 months
  • Professor Peter Shepherd
    The University of Auckland
    The metabolic effect of antipsychotic medication
    $820,149
    24 months
  • Professor Peter Shepherd
    The University of Auckland
    A new role for beta-catenin as a sensor for changes in glucose levels
    $653,317
    36 months
  • Professor Peter Shepherd
    The University of Auckland
    Regulating hormone secretion via dynamic modulation of beta-catenin levels
    $1,187,711
    36 months
  • Professor Peter Shepherd
    University of Auckland
    Potentiation of targeted cancer therapies by statins
    $1,174,005
    36 months
  • Professor Peter Shepherd
    The University of Auckland
    A new combination therapy for cancer
    $1,166,624
    36 months
  • Dr Timothy Short
    Auckland District Health Board
    The Influence of Anaesthetic Depth on Patient Outcome after Major Surgery
    $1,199,005
    36 months
  • Associate Professor Louise Signal
    University of Otago, Wellington
    C3 - Cancer Care Journeys and Clinical Decision Making
    $1,198,742
    36 months
  • Dr Leigh Signal
    Massey University
    Sleep in pregnancy and postpartum: the relationship to maternal health
    $945,456
    36 months
  • Dr Louise Signal
    University of Otago, Wellington
    Is Junk Food Promoted through Sport?
    $501,489
    36 months
  • Ms Victoria Simon
    Massey University
    Workplace safety for Māori nurses
    $50,690
    18 months
  • Dr Jeffrey Smaill
    The University of Auckland
    Novel small molecule therapeutics for treatment of smoking-related lung cancer
    $1,180,810
    36 months
  • Ms Kirsten Smiler
    Victoria Link Limited
    Partnership: refocusing successful interventions for Māori deaf/hearing impaired children
    $196,923
    36 months
  • Dr Cherryl Smith
    Te Runanga o Ngati Apa
    Health, cultural and social experiences of Māori affected by chemical related illness
    $275,625
    36 months
  • Associate Professor Christian Soeller
    The University of Auckland
    The Relationship of Nano-structure and Function of Myocytes in Heart Failure
    $1,090,883
    36 months
  • Associate Professor Faafetai Sopoaga
    University of Otago, Dunedin
    Mental health and wellbeing of Pacific youth in higher education
    $599,336
    36 months
  • Mr Andrew Sporle
    The University of Auckland
    Preventable Maori mortality
    $1,199,945
    36 months
  • Mr Andrew Sporle
    Independent Researcher, Auckland
    Te Hao Nui
    $1,198,494
    36 months
  • Dr Mark Staiger
    University of Canterbury
    Degradable metallic mini-plate and screw system for craniofacial osteosynthesis
    $692,737
    30 months
  • Associate Professor Lisa Stamp
    University of Otago, Christchurch
    Safety and Efficacy of High Dose Allopurinol in the Management of Gout: A Randomised Interventional Study
    $1,199,225
    36 months
  • Associate Professor Lisa Stamp
    University of Otago, Christchurch
    Predicting response to anti-TNF therapy based on serum cytokine and gene profile
    $1,199,969
    36 months
  • Professor Lisa Stamp
    University of Otago, Christchurch
    Is prophylaxis required with start-low go slow dosing of allopurinol in gout?
    $1,432,108
    48 months
  • Dr James Stanley
    University of Otago, Wellington
    The impact of racism on the future health of adults: a prospective cohort study
    $818,257
    36 months
  • Professor Nicola Starkey
    University of Waikato
    Patterns of recovery from concussion in children and adolescents
    $1,197,414
    36 months
  • Professor Ralph Stewart
    Auckland District Health Board
    Improving outcomes of patients with atrial fibrillation in primary care
    $1,196,335
    36 months
  • Dr Cathy Stinear
    The University of Auckland
    TRIO: Targeted Rehabilitation, Improved Outcomes
    $1,126,268
    36 months
  • Professor Timothy Stokes
    University of Otago, Dunedin
    Do regional DHB groupings improve service integration and health outcomes?
    $799,562
    24 months
  • Dr Martin Sullivan
    Massey University
    A longitudinal study of the life histories of people with spinal cord injury
    $897,876
    48 months
  • Dr Gerhard Sundborn
    University of Auckland
    Communities fighting sugar in soft drinks
    $1,176,875
    48 months
  • Dr Gerhard Sundborn
    The University of Auckland
    How has a 'water only' and 'healthy kai' school policy impacted on child obesity
    $553,966
    36 months
  • Dr Gerhard Sundborn
    The University of Auckland
    Understanding scabies prevalence to improve the health of Masifika/Māori kids
    $594,346
    36 months
  • Professor Boyd Swinburn
    The University of Auckland
    Food environments in New Zealand: Policies and impacts on health and equity
    $1,162,422
    36 months
  • Associate Professor Peter Sykes
    University of Otago, Christchurch
    The conservative management of young women with CIN2
    $1,196,179
    48 months
  • Dr El-Shadan Tautolo
    Auckland University of Technology
    Respiratory health of Pacific youth: Risk and resilience throughout childhood
    $1,183,935
    36 months
  • Dr El-Shadan Tautolo
    Auckland University of Technology
    Pacific Islands Families: Cultural resilency and vulnerability in mental health
    $1,189,886
    36 months
  • Dr Merryn Tawhai
    The University of Auckland
    Predicting pulmonary hypertension
    $996,896
    36 months
  • Dr Denise Taylor
    AUT University
    Low-cost Telerehabilitation to Improve Outcomes for People with Chronic Stroke
    $986,660
    36 months
  • Dr Rachael Taylor
    University of Otago, Dunedin
    Screening, feedback and treatment in overweight 4-8 year old children
    $1,307,272
    36 months
  • Dr Rachael Taylor
    University of Otago, Dunedin
    Improving school playgrounds to enhance physical activity in children
    $799,244
    36 months
  • Professor Barry Taylor
    University of Otago, Dunedin
    Primary prevention of rapid weight gain in early childhood
    $2,179,960
    36 months
  • Associate Professor Robin Taylor
    University of Otago
    Predicting response to corticosteriods in COPD using exhaled nitric oxide
    $374,211
    18 months
  • Professor Barry Taylor
    University of Otago, Dunedin
    Prevention of Overweight in Infancy (POI): the Emergence of Self-regulation
    $901,013
    36 months
  • Associate Professor Rachael Taylor
    University of Otago, Dunedin
    Prevention of Overweight in Infancy (POI): Follow-up to Five Years
    $1,198,083
    36 months
  • Professor Barry Taylor
    University of Otago, Dunedin
    Safer Sleeping Environments: Evaluating new options for New Zealand babies
    $1,199,740
    36 months
  • Professor Rachael Taylor
    University of Otago
    Does a brief sleep intervention in infancy have long-term health benefits?
    $1,190,308
    36 months
  • Dr Martin Than
    Canterbury District Health Board
    Can an 'Accelerated pathway' Reduce Admissions for Chest Pain in New Zealand?
    $899,710
    27 months
  • Dr Martin Than
    Canterbury District Health Board
    Can a New 'Australasian Risk Score' Reduce Chest Pain Admissions in New Zealand
    $730,040
    22 months
  • Dr Martin Than
    Canterbury District Health Board
    iCare-FASTER improving care by FAster risk-STratification in the EmeRgency department
    $1,152,385
    36 months
  • Dr Alice Theadom
    AUT University
    Prevalence and impact of inherited myopathies in New Zealand
    $1,198,076
    36 months
  • Dr Benjamin Thompson
    The University of Auckland
    A randomized clinical trial of a new binocular treatment for amblyopia
    $1,167,538
    36 months
  • Dr John Thompson
    The University of Auckland
    Quality of care and outcomes in children with cleft lip and/or palate
    $1,005,314
    48 months
  • Associate Professor John Thompson
    University of Auckland
    Environmental and genetic risk factors for cleft lip and palate
    $1,198,687
    60 months
  • Dr George Thomson
    University of Otago, Wellington
    Policymaking to reduce smoking around children
    $700,445
    36 months
  • Professor Peter Thorne
    The University of Auckland
    Imaging the labyrinthine-blood barrier in Meniere's disease
    $966,266
    36 months
  • Professor Peter Thorne
    The University of Auckland
    Abnormal ion homeostasis in inner ear disease
    $1,273,525
    36 months
  • Dr Jemaima Tiatia-Seath
    The University of Auckland
    Climate change and mental wellbeing: The impacts on Pacific peoples
    $589,691
    36 months
  • Dr Sandar Tin Tin
    The University of Auckland
    Taupo Bicycle Study: Follow-up of a cohort of cyclists
    $640,602
    48 months
  • Dr Adrian Trenholme
    Counties Manukau District Health Board
    Intervention study of children at high risk of chronic lung disease
    $1,198,758
    36 months
  • Professor Richard Troughton
    University of Otago, Christchurch
    Reducing the burden of atrial fibrillation
    $1,087,437
    36 months
  • Professor Richard Troughton
    University of Otago, Christchurch
    Reducing heart failure readmission: The IMPERATIVE-HF study
    $709,275
    36 months
  • Professor Richard Troughton
    University of Otago, Christchurch
    Dietary sodium reduction to improve heart failure outcomes: The SODIUM-HF study
    $1,412,362
    36 months
  • Dr James Ussher
    University of Otago
    The role of microbial viability in regulating MAIT cell activation
    $1,191,634
    36 months
  • Dr Mark Vickers
    The University of Auckland
    Developmental programming of disease: critical windows for intervention
    $943,647
    36 months
  • Professor Mark Vickers
    The University of Auckland
    Circulating miRNAs in maternal blood as biomarkers for preterm birth
    $1,142,110
    36 months
  • Dr Margaret Vissers
    University of Otago, Christchurch
    Ascorbate-mediated Regulation of HIF-1 Mediated Tumour Growth and Angiogenesis
    $812,985
    36 months
  • Mr Andrew Waa
    University of Otago, Wellington
    Te ara auahi kore
    $1,189,413
    48 months
  • Ms Cathrine Waetford
    AUT University
    Health measurement and knowledge translation for improved Māori health outcomes
    $417,189
    18 months
  • Dr Natalie Walker
    The University of Auckland
    Cytisine - a promising low cost intervention for smoking cessation
    $1,180,705
    30 months
  • Professor Robert Walker
    University of Otago, Dunedin
    Dialysis Outcomes in those aged 65 years and over
    $772,060
    36 months
  • Dr Natalie Walker
    The University of Auckland
    The combined use of nicotine replacement therapy and e-cigarettes
    $1,199,916
    36 months
  • Associate Professor Natalie Walker
    University of Auckland
    Smoking relapse prevention in COPD patients
    $1,195,250
    36 months
  • Associate Professor Natalie Walker
    University of Auckland
    A head-to-head trial of cytisine and varenicline for smoking cessation
    $1,599,944
    36 months
  • Dr Logan Walker
    University of Otago, Christchurch
    Genetic modifiers of risk of familial breast and ovarian cancer
    $1,142,728
    36 months
  • Associate Professor Logan Walker
    University of Otago
    Impact of germline copy number variation on endometrial cancer risk
    $1,145,197
    36 months
  • Dr Susan Wells
    The University of Auckland
    Cardiovascular risk prediction for New Zealanders - beyond Framingham
    $1,321,281
    36 months
  • Dr Robyn Whittaker
    The University of Auckland
    A trial of a mobile phone-based depression prevention programme for adolescents
    $1,741,371
    36 months
  • Dr Robyn Whittaker
    Auckland UniServices Ltd
    Can a multimedia mobile phone programme help young people stop smoking?
    $1,553,670
    36 months
  • Dr Kirsten Wickens
    University of Otago, Wellington
    A Maternal Probiotic Intervention for Infant Allergic Disease Prevention
    $1,181,991
    36 months
  • Dr Kristin Wickens
    University of Otago, Wellington
    Six year follow-up of the effects of probiotics on development of allergic disease
    $986,784
    24 months
  • Dr Janine Wiles
    The University of Auckland
    Resilient aging in place: Improving the lives of older people in NZ communities
    $771,894
    36 months
  • Dr Marc Wilson
    Victoria University of Wellington
    Longitudinal Study of Developmental and Cessation of Self-harm among Adolescents
    $1,122,650
    48 months
  • Professor William Wilson
    The University of Auckland
    Exploiting hypoxia and DNA repair defects in triple negative breast cancer
    $1,184,058
    36 months
  • Professor William Wilson
    The University of Auckland
    Pharmacokinetics and pharmacodynamics of the hypoxia-activated prodrug PR-104 plasticity
    $1,157,615
    36 months
  • Dr Denise Wilson
    Massey University
    Nursing and Māori patient outcomes
    $311,620
    15 months
  • Dr Nicholas Wilson
    University of Otago
    Longitudinal study of smokers for tobacco control: NZ arm of multi-country study
    $1,429,126
    36 months
  • Professor John Windsor
    The University of Auckland
    Toxicity of Mesenteric Lymph in Critical Illness
    $1,134,445
    36 months
  • Professor John Windsor
    The University of Auckland
    Mitochondria in multiple organ dysfunction syndrome
    $679,561
    36 months
  • Professor John Windsor
    University of Auckland
    Targeting toxic gut lymph to treat acute disease
    $1,176,441
    36 months
  • Professor John Windsor
    University of Auckland
    Establishing drainage of thoracic duct lymph for longitudinal clinical studies
    $1,158,581
    48 months
  • Professor Christine Winterbourn
    University of Otago, Christchurch
    Neutrophil oxidants in infection and inflammation
    $1,588,079
    36 months
  • Associate Professor Karen Witten
    Massey University
    Children's mobility and physical activity in higher density urban neighbourhoods
    $1,186,407
    36 months
  • Professor Karen Witten
    Massey Universisty, Auckland
    Enabling participation for children and young people with disabilities
    $784,464
    36 months
  • Dr Conroy Wong
    Counties Manukau District Health Board, Auckland
    A Randomised Trial of Tiotropium Treatment for Bronchiectasis
    $1,198,253
    36 months
  • Dr Conroy Wong
    Counties Manukau District Health Board
    Prophylactic azithromycin for bronchiectasis: A randomised, controlled trial
    $1,347,563
    30 months
  • Associate Professor Lianne Woodward
    University of Canterbury
    Neurological Development of the Very Preterm Infant: A Longitudinal Study
    $923,902
    36 months
  • Associate Professor Lianne Woodward
    University of Canterbury
    Childhood exposure to family violence and later parenting risk
    $767,909
    36 months
  • Dr Emma Wyeth
    University of Otago
    POIS-10 Māori: Outcomes and experiences in the decade following injury
    $1,191,067
    36 months
  • Professor Tim Yandle
    University of Otago
    Variable structure and activity of B-type natriuretic peptides in heart disease
    $673,903
    36 months
  • Dr Deborah Young
    The University of Auckland
    Self-regulating gene therapy for Parkinson's disease
    $1,166,710
    36 months
  • Associate Professor Alistair A Young
    The University of Auckland
    Cardiac MRI During Exercise: Ventricular and Vascular Function
    $1,165,090
    36 months
  • Dr Deborah Young
    The University of Auckland
    Driving neurogenesis as a therapeutic strategy for age-related cognitive decline
    $991,955
    36 months
  • Dr Alistair A Young
    The University of Auckland
    Detailed myocardial function in vascular disease using displacement encoded MRI
    $1,069,163
    36 months
  • Dr Paul Young
    Medical Research Institute of New Zealand
    A cluster RCT of selective decontamination of the digestive tract in the Intensive Care Unit
    $1,200,000
    36 months
  • Dr Paul Young
    Medical Research Institute of New Zealand
    TARGET (The Augmented versus Routine approach to Giving Energy Trial)
    $1,200,000
    48 months
  • Dr Paul Young
    Medical Research Institute of New Zealand
    ICU-ROX: An ICU RCT of conservative vs. standard oxygen therapy
    $1,404,525
    42 months
  • Dr Paul Young
    Medical Research Institute of New Zealand
    The PLUS trial: PLasmalyte versUs Saline for intravenous fluid therapy in ICU
    $1,385,525
    42 months
  • Professor Alistair Young
    University of Auckland
    Left ventricular remodelling in the multi-ethnic study of atherosclerosis
    $1,188,399
    36 months
  • Dr Paul Young
    Medical Research Institute of New Zealand
    Targeted Early Activity and Mobilisation in the ICU (the TEAM study)
    $1,011,247
    48 months
  • Dr Jichao Zhao
    University of Auckland
    Targeting human atrial microstructure: The key to resolving atrial fibrillation
    $1,178,146
    36 months
  • Dr Andrea ‘t Mannetje
    Pesticide exposure and early biomarkers of non-Hodgkin lymphoma risk in farmers
    $1,196,460
    36 months
  • Dr Andrea ’t Mannetje
    Massey University, Wellington
    MOBI-KIDS New Zealand: Risk Factors for Brain Cancer in Children and Adolescents
    $466,148
    36 months